In vitro 3D skeletal muscle tissue models are essential platforms for disease modeling, drug discovery, and bio-hybrid robotics. However, replicating native muscle architecture and achieving functional myotube alignment remain significant biofabrication challenges. In this study, we developed a novel composite bioink (MFG)—combining Matrigel, fibrinogen, and gelatin methacrylate (GelMA)—specifically engineered for extrusion-based 3D bioprinting. GelMA provides printability and shape fidelity without requiring sacrificial supports, while Matrigel and fibrin recreate a biomimetic extracellular matrix (ECM) rich in biochemical signals. Following optimization of bioprinting parameters, C2C12 cell-laden MFG constructs were crosslinked through a sequential multi-step strategy combining photo-polymerization, thermal gelation, and enzymatic thrombin treatment. The resulting MFG constructs exhibited a physiological compressive Young’s modulus of 6.4 ± 0.6 kPa and controlled degradation over 7 days, promoting local matrix remodeling. Viability assays confirmed high cell survival exceeding 21 days. To decouple matrix composition from geometrical cues, constructs with anisotropic (rod) and isotropic (circle) regions were printed using MFG and pure GelMA controls. Quantitative nuclear morphometric analysis revealed that C2C12 cells embedded in the rod region of MFG constructs achieved progressive nuclear elongation and a tight alignment along the printing axis (>38% ±10° at Day 21). Notably, immunofluorescence demonstrated robust titin expression and multinucleated myotube assembly exclusively in MFG constructs, whereas GelMA controls failed to promote alignment or myogenesis. These findings demonstrate that both biomimetic ECM chemistry and contact guidance from bioprinted geometry are essential for skeletal muscle maturation.